Michelle Fay Cortez
What a `Right to Try' Might Mean for Dying Patients: QuickTake
Drugmakers Try a Rare Tactic to Boost Sales: Cutting the Price
Regeneron, Sanofi Cut Heart Drug's Price as Trial Disappoints
Regeneron's Eylea Inflammation Risk Tied to Syringes
National Rifle Association reduces gun injuries in U.S. for 3 days every year when it holds its annual convention.
Esperion Targets $10 a Day for Heart Pill, Undercutting Rivals
Medtronic Puts Woes in Past With Soaring Sales in Diabetes Unit
Regeneron's Eye Drug Has Mysterious Rise in Side Effect Reports
We Could Be Turning the Corner on the Flu
U.S. FDA wants to let drugmakers test Alzheimer’s treatments on patients years before disease shows outward signs.
Merck & Co. to end the final-stage testing of a drug, once considered a potential alternative to treat Alzheimer’s.
Flu Caused 1 in 10 American Deaths Last Week
Early Prostate Cancer Kept at Bay in 2 Studies for High-Risk Men
Scientist in charge cautions against drawing conclusions about impact on humans.
Hospitals Overflow as Flu Epidemic Spreads Unabated
Trump's Endorsement Puts `Right to Try' Drug Bill on Fast Track
Kids are driving influenza infections in schools. More than 50,000 deaths are expected before it finally ends.
Flu Epidemic Gets Worse Just in Time For Funding Shutdown
Think Flu Season is Bad? It Might Get Even Worse
The CEO President Is Getting a Physical. What About Your CEO?
Novel approach will tie cost of medicine to patients’ benefit.